ArticleScientific reports2025
Investigating the efficacy of bioactive compounds from selected plant extracts against Gibberella fujikuroi species complex associated with damping off disease in sweet corn.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Essential Oils ofPathogens (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Fusarium genera are widespread disease-causing fungi that severely reduce plant productivity and yield quality, particularly in corn. In this study, we investigated the antifungal potential of selected plant extracts against damping-off disease-associated fungi in sweet corn (Zea mays L. saccharata). Fourteen Fusarium isolates were obtained from symptomatic sweet corn plants belonging to five different species, viz. F. fujikuroi, F. proliferatum, F. verticillioides, F. oxysporum, and F. acuminatum. Although all the isolated fungi were pathogenic, F. verticillioides (Fv-A), F. fujikuroi (Ff-A) and F. oxysporum (Fo-W2) were more aggressive showing higher values for infection (%) and infection severity (%) and negatively affected seed germination (%) and other growth variables. Phytochemical analysis for five wildly growing plant species namely; Eruca vesicaria L., Strigosella africana L., Chenopodium album L., Oxalis pes-caprae L. and Ducrosia ismaelis was conducted using GC-MS analysis. The most abundant bioactive compounds in the three selected extracts (E. vesicaria, O. pes-caprae L. and D. ismaelis) were 1-eicosanol, (Z)6,(Z)9-Pentadecadien-1-ol and n-Hexadecanoic acid, and Nonadecane, respectively. Oxacyclotricosan-2-one and D-Homoandrostane from E. vesicaria L.; Vitamin E and Benzenepropanoic acid, 3,5-bis(1,1-dimethylethyl)-4-hydroxy-, methyl ester from O. pes-caprae L. and 7.beta.-(1-hydroxy-1-methylethyl), alpha-gurjunene from D. ismaelis showed extraordinary molecular docking and dynamic properties including high binding free energy, relatively low inhibition constant (pKi), ligand efficiency, and low torsional energy against three fungal enzymes, namely GH10 xylanase, Plant-type chitinase inhibitors, and Sterol 14-alpha Demethylase. Thus, these bioactive compounds can be listed as potential binders of these target proteins and could be used in designing new fungicides.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.